90621 Menb-fhbp vacc 2/3 dose intramuscular
Medicine
Also known as: MenB-fHBP vaccine, bexsero
Meningococcal group B vaccine factor H binding protein administered intramuscularly in 2 or 3-dose series.
Clinical Context
Recombinant meningococcal group B vaccine using factor H binding protein antigen, administered in 2 to 3-dose series for serogroup B protection.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.